Therapy of small breast cancer - four-year results of a prospective non-randomized study The German Breast Cancer Study Group (GBSG)H. F. RauscheckerC. Schmoor Report Pages: 1 - 13
A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer M. C. AlonsoJ. M. TaberneroJ. J. López Report Pages: 15 - 24
Genetic evolution of breast cancers III: Age-dependent variations in the correlations between biological indicators of prognosis Yorghos RemvikosHenri MagdelenatBernard Dutrillaux Report Pages: 25 - 33
Induction of ductal carcinomas by intraductal administration of 7,12-dimethylbenz(a)anthracene in Wistar rats Susumu TeradaKiyoshi UchideEturo Nishida Report Pages: 35 - 43
Polyamine profiles and growth properties of ornithine decarboxylase overexpressing MCF-7 breast cancer cells in culture Andrea ManniRita WechterLaurence Demers Report Pages: 45 - 53
Body fat distribution in relation to breast cancer in women participating in the DOM-project Isolde den TonkelaarJacob C. SeidellHubertine J. A. Collette Report Pages: 55 - 61
In vitro activity of taxol and taxotere in comparison with doxorubicin and cisplatin on primary cell cultures of human breast cancers Wainer ZoliAlberto FlamigniAnna Gasperi-Campani Report Pages: 63 - 69
Parity is associated with axillary nodal involvement in operable breast cancer Richard K. OrrKathleen M. Fraher Report Pages: 71 - 76
Should tamoxifen be a primary treatment choice for elderly breast cancer patients with locoregional disease? L. BergmanJ. A. van DongenF. E. van Leeuwen Report Pages: 77 - 83
